takeaway
trade higher day better-than-expect organ growth dental
best yr modest ep beat/rais howev margin
surprisingli weak rel top line strength rebound dental
consum buy-in non-control interest help lift ep
stock rebound recent low valuat back
premium see risk/reward balanc current level
 dental consum great dental consum growth
beat forecast reflect nice q/q uptick vs
mark best level sinc lap easi comp two-yr stack
adjust extra sell day puts/tak heartland contract loss
preciou metal exit note comp-adjust trend larg consist
last quarter management attribut growth
share gain rather uptick broader offic visit
solid momentum anim ah core rev grew howev
adjust switch buy/sel agenc relationship underli core growth
includ america similar fairli stabl
two-yr stack sustain next year believ elev level growth
support newco captur premium high-teen ebitda multipl post-spin
margin pressur continu restructur plan tap despit rel
strong organ growth deterior anoth y/i dso contract
headwind partli blame also cite invest equip servic rep
technic support ahead schein one jv launch also believ margin
eros structur due custom consolid dso gpos/buy group
management also acknowledg greater price transpar market on-line player
dynam go away time soon respons outlin
restructur plan take mo full payback see plan like
help support stand-alon ep growth expect hsd/ ldd next year
low-qual guidanc bump rais low-end ep guidanc
mid-pt penni first hike
believ outlook mostli benefit earlier expect buy-in
non-control interest anim line off-set weaker opm
think market mostli gloss dynam yesterday
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
million except per share data
page
pleas see import disclosur inform page report
vs growthv expectationsprior yearforecastreportedactualpercentactualpercentepsnet product expens incom share share analysisgross sg ebitda oper incom incom net
million except per share data
page
pleas see import disclosur inform page report
histor earn per flow cash cash flow cash flow per cash net interest free cash stock-bas sheet metricsreceiv day day day convers interest debt ttm debt ttm valu per
histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor net product expens incom share share analysisgross sg ebitda oper incom net growth analysisnet sg oper net dilut
lead multi-n distributor healthcar product servic office-bas practition includ dental
practition laboratori physician practic anim health clinic world-wide
pt repres horizon dcf impli ev ebitda price-to-earnings line w/ risk competit
brandon couillard certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
matthew stanton certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
michael koban certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
case jefferi employe analyst respons coverag financi instrument discuss report receiv
compens base part overal perform firm includ invest bank incom seek updat research
appropri variou regul may prevent us asid certain industri report publish period basi larg major
report publish irregular interv appropri analyst judgement
articl articl
